Anti-CD71, Recombinant [BU54]
Invented at University Of Birmingham
- Datasheet
- References (1)
- Inventor Info
Info
| Catalogue Number | 153265 |
| Applications | FACS |
| Antigen/Gene or Protein Targets | CD71 |
| Synonyms | Transferrin Receptor; TFR1; TRFR; P90; TFR; TR; T9; Transferrin Receptor (P90; CD71); CD71 Antigen; IMD46; CD71 |
| Reactivity | Human |
| Relevance | CD71 is a transferrin receptor located on the cellular surface necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. |
| Host | Mouse |
| Immunogen | Robbins Myeloma |
| Subclass | IgG1 |
| Formulation | PBS |
| Concentration | 1mgml-1 |
| Research Area | Immunology |
| Notes |
Recombinant monoclonal antibody produced from the original monoclonal cell line. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma. Five products based on this clone: - Anti-CD71 [BU54], Mouse IgG1, Kappa - Anti-CD71 [BU54], Rabbit IgG, Kappa - Anti-CD71 [BU54], Human IgG4-S228P, Kappa - Anti-CD71 [BU54], Human IgG1, Kappa - Anti-CD71 [BU54], Human IgG1, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors |
References: 1 entry
Original hybridoma first published in: Schlossman, S.F. et al. 1989 Leukocyte Typing IV Oxford University Press
Add a reference
References: 1 entry
Original hybridoma first published in: Schlossman, S.F. et al. 1989 Leukocyte Typing IV Oxford University Press
Add a reference
